Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Fentanyl Aerosol for Breakthrough Cancer Pain
NCT04713189Phase 2Unknown
- Sponsor
- Lee's Pharmaceutical Holdings Limited
- Start
- Mar 2021
- Primary completion
- Dec 2021
- Modality
- Orthosteric Ligands
01
Overview
A Phase 2 trial of fentanyl in breakthrough cancer pain (BTcP), sponsored by Lee's Pharmaceutical Holdings Limited. Status: unknown.
02
Drugs
fentanyl
03
Conditions
breakthrough cancer pain (BTcP)
Beyond the preview
Go deeper on NCT04713189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04713189.